329 related articles for article (PubMed ID: 22470494)
1. Chronic immune activation in HIV-1 infection contributes to reduced interferon alpha production via enhanced CD40:CD40 ligand interaction.
Donhauser N; Pritschet K; Helm M; Harrer T; Schuster P; Ries M; Bischof G; Vollmer J; Smola S; Schmidt B;
PLoS One; 2012; 7(3):e33925. PubMed ID: 22470494
[TBL] [Abstract][Full Text] [Related]
2. Decreased CD40 ligand induction in CD4 T cells and dysregulated IL-12 production during HIV infection.
Vanham G; Penne L; Devalck J; Kestens L; Colebunders R; Bosmans E; Thielemans K; Ceuppens JL
Clin Exp Immunol; 1999 Aug; 117(2):335-42. PubMed ID: 10444266
[TBL] [Abstract][Full Text] [Related]
3. CD40 ligand and IFN-gamma synergistically restore IL-12 production in HIV-infected patients.
Chougnet C; Thomas E; Landay AL; Kessler HA; Buchbinder S; Scheer S; Shearer GM
Eur J Immunol; 1998 Feb; 28(2):646-56. PubMed ID: 9521075
[TBL] [Abstract][Full Text] [Related]
4. Cooperation of TNF family members CD40 ligand, receptor activator of NF-kappa B ligand, and TNF-alpha in the activation of dendritic cells and the expansion of viral specific CD8+ T cell memory responses in HIV-1-infected and HIV-1-uninfected individuals.
Yu Q; Gu JX; Kovacs C; Freedman J; Thomas EK; Ostrowski MA
J Immunol; 2003 Feb; 170(4):1797-805. PubMed ID: 12574344
[TBL] [Abstract][Full Text] [Related]
5. Inability of plasmacytoid dendritic cells to directly lyse HIV-infected autologous CD4+ T cells despite induction of tumor necrosis factor-related apoptosis-inducing ligand.
Chehimi J; Papasavvas E; Tomescu C; Gekonge B; Abdulhaqq S; Raymond A; Hancock A; Vinekar K; Carty C; Reynolds G; Pistilli M; Mounzer K; Kostman J; Montaner LJ
J Virol; 2010 Mar; 84(6):2762-73. PubMed ID: 20042498
[TBL] [Abstract][Full Text] [Related]
6. CD40 ligand trimer and IL-12 enhance peripheral blood mononuclear cells and CD4+ T cell proliferation and production of IFN-gamma in response to p24 antigen in HIV-infected individuals: potential contribution of anergy to HIV-specific unresponsiveness.
Dybul M; Mercier G; Belson M; Hallahan CW; Liu S; Perry C; Herpin B; Ehler L; Davey RT; Metcalf JA; Mican JM; Seder RA; Fauci AS
J Immunol; 2000 Aug; 165(3):1685-91. PubMed ID: 10903780
[TBL] [Abstract][Full Text] [Related]
7. Increased interferon alpha expression in circulating plasmacytoid dendritic cells of HIV-1-infected patients.
Lehmann C; Harper JM; Taubert D; Hartmann P; Fätkenheuer G; Jung N; van Lunzen J; Stellbrink HJ; Gallo RC; Romerio F
J Acquir Immune Defic Syndr; 2008 Aug; 48(5):522-30. PubMed ID: 18645522
[TBL] [Abstract][Full Text] [Related]
8. Anti-CD40 Antibody Fused to CD40 Ligand Is a Superagonist Platform for Adjuvant Intrinsic DC-Targeting Vaccines.
Ceglia V; Zurawski S; Montes M; Kroll M; Bouteau A; Wang Z; Ellis J; Igyártó BZ; Lévy Y; Zurawski G
Front Immunol; 2021; 12():786144. PubMed ID: 35095862
[TBL] [Abstract][Full Text] [Related]
9. Regulation of human immunodeficiency virus type 1 infection, beta-chemokine production, and CCR5 expression in CD40L-stimulated macrophages: immune control of viral entry.
Cotter RL; Zheng J; Che M; Niemann D; Liu Y; He J; Thomas E; Gendelman HE
J Virol; 2001 May; 75(9):4308-20. PubMed ID: 11287580
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of P-class versus other CpG oligodeoxynucleotide classes on the impaired innate immunity of plasmacytoid dendritic cells in HIV type 1 infection.
Donhauser N; Helm M; Pritschet K; Schuster P; Ries M; Korn K; Vollmer J; Schmidt B
AIDS Res Hum Retroviruses; 2010 Feb; 26(2):161-71. PubMed ID: 20156099
[TBL] [Abstract][Full Text] [Related]
11. Polyfunctional CD4(+) T cell responses in HIV-1-infected viral controllers compared with those in healthy recipients of an adjuvanted polyprotein HIV-1 vaccine.
Van Braeckel E; Desombere I; Clement F; Vandekerckhove L; Verhofstede C; Vogelaers D; Leroux-Roels G
Vaccine; 2013 Aug; 31(36):3739-46. PubMed ID: 23707169
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12.
Krug A; Towarowski A; Britsch S; Rothenfusser S; Hornung V; Bals R; Giese T; Engelmann H; Endres S; Krieg AM; Hartmann G
Eur J Immunol; 2001 Oct; 31(10):3026-37. PubMed ID: 11592079
[TBL] [Abstract][Full Text] [Related]
13. Plasmacytoid dendritic cell number and responses to Toll-like receptor 7 and 9 agonists vary in HIV Type 1-infected individuals in relation to clinical state.
Kaushik S; Teque F; Patel M; Fujimura SH; Schmidt B; Levy JA
AIDS Res Hum Retroviruses; 2013 Mar; 29(3):501-10. PubMed ID: 23131038
[TBL] [Abstract][Full Text] [Related]
14. CD40 ligand dysregulation in HIV infection: HIV glycoprotein 120 inhibits signaling cascades upstream of CD40 ligand transcription.
Zhang R; Fichtenbaum CJ; Hildeman DA; Lifson JD; Chougnet C
J Immunol; 2004 Feb; 172(4):2678-86. PubMed ID: 14764743
[TBL] [Abstract][Full Text] [Related]
15. Impaired plasmacytoid dendritic cell (PDC)-NK cell activity in viremic human immunodeficiency virus infection attributable to impairments in both PDC and NK cell function.
Conry SJ; Milkovich KA; Yonkers NL; Rodriguez B; Bernstein HB; Asaad R; Heinzel FP; Tary-Lehmann M; Lederman MM; Anthony DD
J Virol; 2009 Nov; 83(21):11175-87. PubMed ID: 19692459
[TBL] [Abstract][Full Text] [Related]
16. Increased CD40 expression on muscle cells of polymyositis and dermatomyositis: role of CD40-CD40 ligand interaction in IL-6, IL-8, IL-15, and monocyte chemoattractant protein-1 production.
Sugiura T; Kawaguchi Y; Harigai M; Takagi K; Ohta S; Fukasawa C; Hara M; Kamatani N
J Immunol; 2000 Jun; 164(12):6593-600. PubMed ID: 10843719
[TBL] [Abstract][Full Text] [Related]
17. Impact of class A, B and C CpG-oligodeoxynucleotides on in vitro activation of innate immune cells in human immunodeficiency virus-1 infected individuals.
Martinson JA; Tenorio AR; Montoya CJ; Al-Harthi L; Gichinga CN; Krieg AM; Baum LL; Landay AL
Immunology; 2007 Apr; 120(4):526-35. PubMed ID: 17343615
[TBL] [Abstract][Full Text] [Related]
18. Low-level HIV infection of plasmacytoid dendritic cells: onset of cytopathic effects and cell death after PDC maturation.
Schmidt B; Scott I; Whitmore RG; Foster H; Fujimura S; Schmitz J; Levy JA
Virology; 2004 Nov; 329(2):280-8. PubMed ID: 15518808
[TBL] [Abstract][Full Text] [Related]
19. Role of CD40 ligand signaling in defective type 1 cytokine response in human immunodeficiency virus infection.
Subauste CS; Wessendarp M; Smulian AG; Frame PT
J Infect Dis; 2001 Jun; 183(12):1722-31. PubMed ID: 11372024
[TBL] [Abstract][Full Text] [Related]
20. Maturation of dendritic cells for enhanced activation of anti-HIV-1 CD8(+) T cell immunity.
Huang XL; Fan Z; Borowski L; Rinaldo CR
J Leukoc Biol; 2008 Jun; 83(6):1530-40. PubMed ID: 18364435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
